These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6546806)

  • 1. Intragastric bacteria and nitrite after short-term treatment with different doses of antimuscarinic drugs.
    Stockbruegger RW; Seeberg S; Hellner L; Jaup BH; Dotevall G
    Scand J Gastroenterol; 1984 Jan; 19(1):14-23. PubMed ID: 6546806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of different anticholinergics on the gastric acid response to sham feeding in man.
    Stenquist B; Haglund U; Lind T; Olbe L
    Scand J Gastroenterol Suppl; 1982; 72():165-8. PubMed ID: 6957985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of different doses of pirenzepine on gastric secretion stimulated by modified shamfeeding in man.
    Stockbrügger RW; Jaup BH; Dotevall G
    Scand J Gastroenterol Suppl; 1982; 72():111-7. PubMed ID: 6957978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of two doses of pirenzepine on histamine-stimulated gastric acid secretion in man.
    Eugenides N; Stockbrügger RW; Hobsley M; Cotton PB
    Scand J Gastroenterol Suppl; 1982; 72():125-9. PubMed ID: 6957980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of a 100 mg pirenzepine--treatment on acid secretion and serum gastrin.
    Fritsch WP; Scholten T; Müller J; Hengels KJ; Hanrath KD
    Scand J Gastroenterol Suppl; 1982; 72():173-7. PubMed ID: 6957987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of selective and non-selective antimuscarinics on rectosigmoid motility and gastrointestinal transit.
    Jaup BH; Abrahamsson H; Stockbruegger RW; Rosengren K; Dotevall G
    Scand J Gastroenterol; 1985 Nov; 20(9):1101-9. PubMed ID: 3841410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of intravenous pirenzepine on gastric acid and pepsin in man.
    el-Sabbagh HN; Prinz RA; Welbourn RB; Baron JH
    Scand J Gastroenterol Suppl; 1980; 66():73-7. PubMed ID: 6787694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on gastric bicarbonate secretion in man.
    Forssell H
    Acta Chir Scand Suppl; 1987; 540():1-54. PubMed ID: 3477932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single nocturnal doses of pirenzepine effectively inhibit overnight gastric secretion.
    Howden CW; Burget DW; Silletti C; Hunt RH
    Hepatogastroenterology; 1985 Oct; 32(5):240-2. PubMed ID: 2867023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telenzepine, a new M1-receptor antagonist, is a more potent inhibitor of pentagastrin-stimulated gastric acid output than pirenzepine in dogs.
    Holtmann G; Küppers U; Singer MV
    Scand J Gastroenterol; 1990 Mar; 25(3):293-7. PubMed ID: 2320949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The intragastric milieu during gastric ulcer treatment with pirenzepine 50 mg b.i.d. or cimetidine 400 mg b.i.d.
    Stockbrügger RW; Cronstedt J; Dotevall G; Hellner L; Hoffmann P; Hradsky M; Jaup BH; Seeberg S
    Z Gastroenterol; 1988 Nov; 26(11):685-8. PubMed ID: 3059703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholecystokinin in the control of gastric acid and plasma gastrin and somatostatin secretion in healthy subjects and duodenal ulcer patients before and after eradication of Helicobacter pylori.
    Konturek JW
    J Physiol Pharmacol; 1994 Dec; 45(4 Suppl 1):3-66. PubMed ID: 7787215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of pirenzepine on meal-stimulated acid secretion and gastrin release in normal man.
    Mignon M; Vatier J; Bauer P; Bonfils S
    Scand J Gastroenterol Suppl; 1982; 72():145-51. PubMed ID: 6753112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dose-dependent telenzepine inhibition of the secretion of human gastric acid stimulated by sham feeding and saliva].
    Müller P; Dammann HG; Simon B
    Z Gastroenterol; 1986 Mar; 24(3):152-6. PubMed ID: 3705659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of pirenzepine on meal-stimulated gastric acid secretion, gastrin release and gastric emptying.
    Bianchi Porro G; Prada A; Parente F; Sangaletti O; Lazzaroni M
    Scand J Gastroenterol Suppl; 1982; 72():159-62. PubMed ID: 6957983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of prolonged treatment of pirenzepine 2HCl on gastric secretion and plasma gastrin levels in rats.
    Okabe S; Tabata K; Kawakami M
    Arzneimittelforschung; 1982; 32(6):664-8. PubMed ID: 6896823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of pirenzepine on L--amino acids stimulated gastric acid secretion and serum gastrin levels in peptic ulcer disease in men.
    Bertoglio S; Anfossi A; Arnulfo G; Valentini P; Berti Riboli E
    Scand J Gastroenterol Suppl; 1982; 72():179-84. PubMed ID: 6957988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of ascorbic acid on the intragastric environment in patients at increased risk of developing gastric cancer.
    Reed PI; Johnston BJ; Walters CL; Hill MJ
    IARC Sci Publ; 1991; (105):139-42. PubMed ID: 1855837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of atropine, pirenzepine and cimetidine on nocturnal gastro-intestinal motility and gastric acid secretion.
    Lederer PC; Thiemann R; Femppel J; Domschke W; Lux G
    Scand J Gastroenterol Suppl; 1982; 72():131-7. PubMed ID: 6957981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of pirenzepine and antacids on postprandial intragastric pH.
    Weberg R; Narverud G; Berstad A
    Hepatogastroenterology; 1983 Oct; 30(5):202-4. PubMed ID: 6688998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.